Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Spectrum Pharma Inc (NQ: SPPI ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Spectrum Pharma Inc < Previous 1 2 3 4 5 6 7 8 9 Next > Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Spectrum Pharmaceuticals Stockholders Vote “FOR” Proposed Transaction with Assertio Holdings, Inc. July 20, 2023 From Spectrum Pharmaceuticals, Inc. Via Business Wire SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI June 30, 2023 From Kahn Swick & Foti, LLC Via Business Wire Are (More) Big Gains Ahead for This Small Cap Biotech Stock? June 28, 2023 With Biomea Fusion's share price nearly halved recently, oversold conditions seem to be setting in. This could be an opportunity for small cap growth investors. Via MarketBeat Topics Initial Public Offering Exposures Securities Market Spectrum Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement May 17, 2023 From Spectrum Pharmaceuticals, Inc. Via Business Wire Undervalued Biotech Stocks to Watch After Enzolytics’ (OTC:ENZC) 300% Run: RMED, SPPI, HALB, VXRT May 12, 2023 Via AB Newswire Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update May 09, 2023 From Spectrum Pharmaceuticals, Inc. Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE - UNVR) May 01, 2023 From Brodsky & Smith LLC Via GlobeNewswire SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI April 25, 2023 From Kahn Swick & Foti, LLC Via Business Wire BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Spectrum Pharmaceuticals, Inc. (Nasdaq – SPPI), BELLUS Health Inc (Nasdaq – BLU), Prometheus Biosciences, Inc. (Nasdaq – RXDX), Univar Solutions Inc. (NYSE – UNVR) April 25, 2023 From Brodsky & Smith LLC Via GlobeNewswire SPPI Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Spectrum Pharmaceuticals, Inc. Is Fair to Shareholders April 25, 2023 From Halper Sadeh LLC Via Business Wire NASDAQ:SPPI Long Term Shareholder Alert: Investigation over Possible Wrongdoing at Spectrum Pharmaceuticals, Inc. March 23, 2023 San Diego, CA -- (SBWIRE) -- 03/23/2023 -- Certain directors of Spectrum Pharmaceuticals, Inc. are under investigation over potential breaches of fiduciary duties. Via SBWire Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update March 22, 2023 From Spectrum Pharmaceuticals, Inc. Via Business Wire Spectrum Pharmaceuticals to Report Fourth Quarter and Full Year 2022 Financial Results and Provide Corporate Update March 17, 2023 From Spectrum Pharmaceuticals, Inc. Via Business Wire Spectrum Pharmaceuticals Receives Permanent J-Code for ROLVEDON™ (eflapegrastim-xnst) Injection (J1449) from U.S. Centers for Medicare & Medicaid Services February 08, 2023 From Spectrum Pharmaceuticals, Inc. Via Business Wire Final Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Spectrum Pharmaceuticals, Inc. (SPPI) Investors of Class Action and to Actively Participate February 03, 2023 From Bronstein, Gewirtz & Grossman, LLC Via Business Wire DEADLINE TODAY: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm February 03, 2023 From The Schall Law Firm Via Business Wire SPPI FINAL DEADLINE TOMORROW: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important February 3 Deadline in Securities Class Action - SPPI February 02, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal DEADLINE TOMORROW: The Schall Law Firm Encourages Investors in Spectrum Pharmaceuticals, Inc. with Losses of $100,000 to Contact the Firm February 02, 2023 From The Schall Law Firm Via Business Wire Spectrum Pharmaceuticals Provides Update on ROLVEDON™ (eflapegrastim-xnst) Injection and Announces Unaudited Fourth Quarter 2022 Financial Results January 31, 2023 From Spectrum Pharmaceuticals, Inc. Via Business Wire Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Investor Notice: Deadline in Lawsuit on February 6, 2023 January 30, 2023 San Diego, CA -- (SBWIRE) -- 01/30/2023 -- The Shareholders Foundation announced a deadline is coming up on February 6, 2023 in the lawsuit filed for certain investors of Spectrum Pharmaceuticals, Inc.... Via SBWire SPPI IMPORTANT DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SPPI January 28, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Spectrum Pharmaceuticals Announces New Employment Inducement Grant for Commercial Staff January 26, 2023 From Spectrum Pharmaceuticals Via Business Wire ROSEN, A LONGSTANDING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI January 24, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI January 22, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, A RESPECTED AND LEADING FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI January 16, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal ROSEN, A LEADING LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI January 13, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal NASDAQ:SPPI Investor Alert: Lawsuit Alleges Misleading Statements by Spectrum Pharmaceuticals, Inc. January 11, 2023 San Diego, CA -- (SBWIRE) -- 01/11/2023 -- An investor, who purchased NASDAQ:SPPI shares, filed a lawsuit against Spectrum Pharmaceuticals, Inc. over alleged violations of Federal Securities Laws. Via SBWire ROSEN, A TOP RANKED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action– SPPI January 10, 2023 From The Rosen Law Firm PA Via GlobeNewswire ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Spectrum Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - SPPI January 07, 2023 Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. Via NewMediaWire Topics Lawsuit Exposures Financial Legal Spectrum Pharmaceuticals Announces Management Changes January 04, 2023 From Spectrum Pharmaceuticals, Inc. Via Business Wire < Previous 1 2 3 4 5 6 7 8 9 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.